首页> 外文期刊>Cellular and molecular biology >Interleukin-6 role in the severity of COVID-19 and intensive care unit stay length
【24h】

Interleukin-6 role in the severity of COVID-19 and intensive care unit stay length

机译:白细胞介素-6在Covid-19和重症监护室的严重程度中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Evaluation of cytokine production in COVIID-19 disease, in which the cytokine storm is one of the most important pathological features in complicated cases, especially interleukin 6 as a pre-inflammatory cytokine that exacerbates the immune response, could help determine the pathophysiology of the disease. Examining the level of this cytokine along with other related factors can help to better understand the pathogenesis of this disease. In this cross-sectional study, 48 patients with COVID-19 whose disease was confirmed by swap testing were evaluated. The demographic information of the individuals, the symptoms of the disease, and the ward in which they were admitted were recorded. Blood samples were taken from patients to test for interleukin-6 levels by electrochemiluminescence immunoassay (ECLIA, Roche Diagnostics). Due to the lack of specific treatment protocols for patients and the use of supportive treatments based on meeting the nutritional needs for all patients, blood albumin levels and nutritional status of patients were also evaluated using Subjective Global Assessment (SGA) Form. Their calorie intake was assessed by calculating the number of calories received based on the type of nutrition and compared to the required amount calculated through the Harris-Benedict equation. 48 laboratory-confirmed 2019-nCoV infected patients were included in the study with the mean age of 46.4 +/- 8.3 years. 21 patients were admitted to the intensive care unit (ICU). There was no significant difference between the ICU admitted and patients admitted inward in terms of demographic characteristics, and history of previous diseases (p > 0.05). The average interleukin 6 (IL-6) in patients was 72.3 +/- 34.4 pg/ml. ICU admitted patients had higher IL6 levels (p=0.001). The mean interleukin 6 level was 89.04 +/- 34.1 pg/ml in patients admitted for less than 7 days and it was significantly higher (119.2 +/- 28.3) in patients hospitalized for more than 7 days (p=0.001). there was no significant difference in terms of nutritional status and albumin level between ICU admitted and ward admitted patients (p >0.05). Our study shows that there may be possible associations of IL6 and disease severity and ICU stay length.
机译:在COVIID-19疾病中,细胞因子风暴是复杂病例中最重要的病理特征之一,尤其是白细胞介素6作为一种加剧免疫反应的炎症前细胞因子,对其产生的细胞因子进行评估有助于确定该疾病的病理生理学。检测这种细胞因子的水平以及其他相关因素有助于更好地了解这种疾病的发病机制。在2019冠状病毒疾病的横断面研究中,对48例经互换试验证实的COVID-19患者进行了评价。记录患者的人口统计信息、疾病症状以及他们入住的病房。通过电化学发光免疫分析法(ECLIA,罗氏诊断公司)从患者身上采集血液样本,检测白细胞介素-6水平。由于缺乏针对患者的具体治疗方案,以及在满足所有患者营养需求的基础上使用支持性治疗,患者的血白蛋白水平和营养状况也采用主观整体评估(SGA)表进行评估。他们的卡路里摄入量是通过根据营养类型计算摄入的卡路里数量来评估的,并与通过哈里斯-本尼迪克特方程计算的所需量进行比较。48名实验室确认的2019名nCoV感染患者被纳入研究,平均年龄为46.4+/-8.3岁。21名患者被送入重症监护病房(ICU)。在人口统计学特征和既往病史方面,ICU住院患者和住院患者之间没有显著差异(p>0.05)。患者的平均白细胞介素6(IL-6)为72.3+/-34.4 pg/ml。ICU入院患者的IL-6水平较高(p=0.001)。在住院时间少于7天的患者中,白细胞介素6的平均水平为89.04+/-34.1 pg/ml,而在住院时间超过7天的患者中,白细胞介素6的平均水平显著高于(119.2+/-28.3)(p=0.001)。ICU患者和病房患者的营养状况和白蛋白水平无显著差异(p>0.05)。我们的研究表明,IL6可能与疾病严重程度和ICU住院时间有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号